Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd - ADR

2
1
NYSE:TEVA (Israel)   ADR
$ 13.50 +0.35 (+2.66%) 11:09 PM EST
At Loss
P/B:
2.02
Market Cap:
$ 14.72B
Enterprise V:
$ 31.65B
Volume:
9.12M
Avg Vol (2M):
12.36M
Also Trade In:
Volume:
9.12M
At Loss
Avg Vol (2M):
12.36M

Business Description

Description
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.
Name Current Vs Industry Vs History
Cash-To-Debt 0.16
Equity-to-Asset 0.17
Debt-to-Equity 2.69
Debt-to-EBITDA 12.94
Interest Coverage 3.1
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.22
Distress
Grey
Safe
Beneish M-Score -2.47
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 73.64
9-Day RSI 70.7
14-Day RSI 69.66
6-1 Month Momentum % 26.63
12-1 Month Momentum % 23.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.02
Quick Ratio 0.69
Cash Ratio 0.26
Days Inventory 179.18
Days Sales Outstanding 80.45
Days Payable 103.76

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.7
Shareholder Yield % 10.89

Financials (Next Earnings Date:2024-05-10 Est.)

TEVA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:TEVA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Teva Pharmaceutical Industries Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 15,846
EPS (TTM) ($) -0.47
Beta 0.89
Volatility % 41.48
14-Day RSI 69.66
14-Day ATR ($) 0.366376
20-Day SMA ($) 12.8355
12-1 Month Momentum % 23.61
52-Week Range ($) 7.085 - 13.56
Shares Outstanding (Mil) 1,120.99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Teva Pharmaceutical Industries Ltd Filings

Filing Date Document Date Form
No Filing Data

Teva Pharmaceutical Industries Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Teva Pharmaceutical Industries Ltd Frequently Asked Questions

What is Teva Pharmaceutical Industries Ltd(TEVA)'s stock price today?
The current price of TEVA is $13.50. The 52 week high of TEVA is $13.56 and 52 week low is $7.09.
When is next earnings date of Teva Pharmaceutical Industries Ltd(TEVA)?
The next earnings date of Teva Pharmaceutical Industries Ltd(TEVA) is 2024-05-10 Est..
Does Teva Pharmaceutical Industries Ltd(TEVA) pay dividends? If so, how much?
Teva Pharmaceutical Industries Ltd(TEVA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1